Furthermore, mTOR has a prognostic value for lymph node metastasis, since its expression in metastatic lymph nodes is associated with poor clinical outcomes [76], but also a potential target for gastric cancer therapy [77]. Here, MTOR is linked to metastatic malignant neoplasm in the lymph nodes.